Company Filing History:
Years Active: 2021
Title: Zoltan Prohaszka: Innovator in Cancer Prognosis
Introduction
Zoltan Prohaszka is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of cancer research, particularly in the area of prognosis prediction. His innovative work has the potential to improve the lives of many patients diagnosed with cancer.
Latest Patents
Zoltan Prohaszka holds a patent for "Methods and kits for predicting prognosis of cancer using soluble mortalin in blood." This patent describes methods for determining the presence or level of soluble mortalin in a body fluid of a subject. It also outlines how this information can be used to predict the prognosis of a subject diagnosed with cancer, such as those with solid tumors. The patent includes kits designed to determine the presence and/or level of soluble mortalin, utilizing at least two distinct antibodies directed against different epitopes of mortalin.
Career Highlights
Throughout his career, Zoltan Prohaszka has worked with esteemed institutions, including Ramot at Tel Aviv University Ltd. and Semmelweis University. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Zoltan Prohaszka has collaborated with Zvi Fishelson, further enhancing his research and development efforts in cancer prognosis.
Conclusion
Zoltan Prohaszka's innovative work in cancer prognosis through his patented methods and kits demonstrates his commitment to advancing medical science. His contributions are invaluable in the ongoing fight against cancer, and his research continues to inspire future innovations in the field.